Leerink Partners and William Blair served as joint bookrunning managers for an offering by Larimar Therapeutics, which was declared effective by the SEC (Bangladesh) on August 1, 2025.
3 reports, 1 independent
Updated Aug 1
Gone quiet
- Reports
- 3
- Developments
- 1
- Repetition
- 67%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Leerink Partners and William Blair served as joint bookrunning managers for an offering by Larimar Therapeutics, which was declared effective by the SEC (Bangladesh) on August 1, 2025.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Leerink partners
U.S. investment bank
-
William Blair & Company
American investment bank
Nothing else this week.
-
Securities and Exchange Commission (Bangladesh)
government regulatory body overseeing the stock market
Related events
Coverage
Newest first; wire copies grouped- GlobeNewswireLarimar Therapeutics Announces Closing of Underwritten Public Offering of Common Stock and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares BALA CYNWYD, Pa., July 31, 2025 (
- GlobeNewswireLarimar Therapeutics Announces Pricing of Underwritten Public Offering BALA CYNWYD, Pa., July 29, 2025 (GLOBE NEWSWIRE) -- Larimar Therapeutics, Inc. (“Larimar”) (Nasdaq: LRMR), a clinical-stage biot
- GlobeNewswireLarimar Therapeutics Announces Proposed Underwritten Public Offering BALA CYNWYD, Pa., July 29, 2025 (GLOBE NEWSWIRE) -- Larimar Therapeutics, Inc. (“Larimar”) (Nasdaq: LRMR), a clinical-stage biotec